Shareholder Temasek backs re-election of Bayer supervisory board chair -WiWo
Reuters
Published Apr 03, 2023 14:53
Updated Apr 03, 2023 18:09
(Corrects attribution to Wirtschaftswoche sources, not Temasek)
BERLIN (Reuters) - Temasek, the sovereign wealth fund of Singapore and a major shareholder in Bayer (ETR:BAYGN), will back re-election of the German pharmaceuticals company's supervisory board chair, the Wirtschaftswoche news outlet reported on Monday, citing unnamed sources.
Shareholders are due to vote on another term for Norbert Winkeljohann at Bayer's annual general meeting on April 28. The drugmaker has been the target of activist investors in the run-up to a change of CEO on June 1.
Temasek wants to facilitate stability and continuity in times of upheaval, the Wirtschaftswoche sources said.
(This story has been corrected to change the attribution to Wirtschaftswoche's sources, not Temasek, in paragraph 3)
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.